Prognostic models in myelodysplastic syndromes

被引：2
|
作者：
Della Porta, Matteo Giovanni [1 ,2 ]
机构：
[1] Fdn Ist Ricovero Cura & Carattere Sci IRCCS Polic, Dept Hematol Oncol, I-27100 Pavia, Italy
[2] Univ Pavia, Dept Internal Med, I-27100 Pavia, Italy
来源：
LANCET HAEMATOLOGY | 2015年 / 2卷 / 06期
关键词：
SCORING SYSTEM; MUTATIONS;
D O I：
10.1016/S2352-3026(15)00110-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E229 / E230
页数：2
相关论文
共 50 条
  • [21] Improving Prognostic Modeling in Myelodysplastic Syndromes
    Nazha, Aziz
    Sekeres, Mikkael A.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (06) : 395 - 401
  • [22] Classification and Prognostic Evaluation of Myelodysplastic Syndromes
    Cazzola, Mario
    Della Porta, Matteo G.
    Travaglino, Erica
    Malcovati, Luca
    SEMINARS IN ONCOLOGY, 2011, 38 (05) : 627 - 634
  • [23] Mouse Models of Myelodysplastic Syndromes
    Beachy, Sarah H.
    Aplan, Peter D.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 24 (02) : 361 - +
  • [24] Mouse models of myelodysplastic syndromes
    Wegrzyn, Joanna
    Lam, Jeffrey C.
    Karsan, Aly
    LEUKEMIA RESEARCH, 2011, 35 (07) : 853 - 862
  • [25] Prognostic models in predicting outcomes in myelodysplastic syndromes after hypomethylating agent failure
    Patel, Sagar S.
    Sekeres, Mikkael A.
    Nazha, Aziz
    LEUKEMIA & LYMPHOMA, 2017, 58 (11) : 2532 - 2539
  • [26] Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System
    van Spronsen, Margot F.
    Ossenkoppele, Gert J.
    Westers, Theresia M.
    van de Loosdrecht, Arjan A.
    EUROPEAN JOURNAL OF CANCER, 2016, 56 : 10 - 20
  • [27] Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromes
    Saumell, Silvia
    Fernandez-Serrano, Miranda
    Mesa, Alba
    Lopez-Cadenas, Felix
    Arenillas, Leonor
    Alfonso, Ana
    Julia Montoro, Maria
    Molero, Antonieta
    Leoz, Pilar
    Riego, Victoria
    Gallur, Laura
    Salamero, Olga
    Navarrete, Mayda
    Tazon-Vega, Barbara
    Ortega, Margarita
    Reig, Oscar
    Roue, Gael
    Calvo, Xavier
    Prosper, Felipe
    Diez-Campelo, Maria
    Valcarcel, David
    LEUKEMIA & LYMPHOMA, 2022, 63 (05) : 1227 - 1235
  • [28] Prognostic role of transfusion requirement in myelodysplastic syndromes
    Salvi, F.
    Gioia, D.
    Cilloni, D.
    Audisio, E.
    Boccomini, C.
    Bonferroni, M.
    Cametti, G.
    Ciravegna, G.
    Darbesio, A.
    Dellacasa, C.
    Ferrero, D.
    Freilone, R.
    Lunghi, M.
    Gallamini, A.
    Gaidano, G.
    Girotto, M.
    Marmont, F.
    Tonso, A.
    Saglio, G.
    Levis, A.
    LEUKEMIA RESEARCH, 2007, 31 : S96 - S96
  • [29] Prognostic Classification and Risk Assessment in Myelodysplastic Syndromes
    Cazzola, Mario
    Malcovati, Luca
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 24 (02) : 459 - +
  • [30] Serum Erythropoietin as Prognostic Marker in Myelodysplastic Syndromes
    Cortesao, Emlia
    Tenreiro, Rita
    Ramos, Sofia
    Pereira, Marta
    Cesar, Paula
    Carda, Jose P.
    Gomes, Marilia
    Rito, Luis
    Magalhaes, Emlia
    Goncalves, Ana C.
    Silva, Nuno C. e
    Geraldes, Catarina
    Pereira, Amelia
    Ribeiro, Leticia
    Nascimento Costa, Jose M.
    Sarmento Ribeiro, Ana B.
    ACTA MEDICA PORTUGUESA, 2015, 28 (06): : 720 - 725
12345